Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment
Articolo
Data di Pubblicazione:
2002
Citazione:
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment / G. Marchetti, L. Meroni, S. Varchetta, V. Terzieva, A. Bandera, D. Manganaro, C. Molteni, D. Trabattoni, S. Fossati, M. Clerici, M. Galli, M. Moroni, F. Franzetti, A. Gori. - In: THE JOURNAL OF INFECTIOUS DISEASES. - ISSN 0022-1899. - 186:5(2002), pp. 606-616. ((Intervento presentato al 8. convegno Conference on Retroviruses and Opportunistic Infections tenutosi a Chicago nel 2001.
Abstract:
Twenty-two patients with CD4(+)cell counts
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
active antiretroviral therapy; HIV-infected patients; recent thymic emigrants; pneumocystis-carinii pneumonia; Pineral hormone melatonin; T-cell homeostasis; subcutaneous interleukin-2; phase-II; lymphocyte apoptosis; primary prophylaxis
Elenco autori:
G. Marchetti, L. Meroni, S. Varchetta, V. Terzieva, A. Bandera, D. Manganaro, C. Molteni, D. Trabattoni, S. Fossati, M. Clerici, M. Galli, M. Moroni, F. Franzetti, A. Gori
Link alla scheda completa: